TY - JOUR
T1 - Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives
AU - Iezzi, Roberto
AU - Posa, Alessandro
AU - Contegiacomo, Andrea
AU - Lee, In Joon
AU - Bale, Reto
AU - Tanzilli, Alessandro
AU - Tenore, Lorenzo
AU - Giuliante, Felice
AU - Gasbarrini, Antonio
AU - Goldberg, Shraga Nahum
AU - Jakobs, Tobias
AU - Pompili, Maurizio
AU - Bargellini, Irene
AU - Sala, Evis
AU - Kim, Hyo-Cheol
PY - 2023
Y1 - 2023
N2 - Simple Summary The aim of this review is to evaluate the different approaches to early-stage hepatocellular carcinoma according to Western and Eastern interventional radiology perspectives based on the most recent literature. Understanding different perspectives and guidelines can help in selecting the correct indication of locoregional procedures (mostly ablation, chemoembolization, and radioembolization) for every patient. Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.
AB - Simple Summary The aim of this review is to evaluate the different approaches to early-stage hepatocellular carcinoma according to Western and Eastern interventional radiology perspectives based on the most recent literature. Understanding different perspectives and guidelines can help in selecting the correct indication of locoregional procedures (mostly ablation, chemoembolization, and radioembolization) for every patient. Hepatocellular carcinoma represents an important cause of death worldwide. Early-stage hepatocellular carcinoma patients not suitable for surgery can be treated with a variety of minimally invasive locoregional interventional oncology techniques. Various guidelines in different countries address the treatment of hepatocellular carcinoma, but the actual treatment is usually discussed by a multidisciplinary tumor board in a personalized manner, leading to potential treatment differences based on Western and Eastern perspectives. The aim of this paper is to integrate literature evidence with the eminent experiences collected during a focused session at the Mediterranean Interventional Oncology (MIO) Live Congress 2023.
KW - ablation
KW - chemoembolization
KW - radioembolization
KW - interventional oncology
KW - locoregional treatments
KW - hepatocellular carcinoma
KW - ablation
KW - chemoembolization
KW - radioembolization
KW - interventional oncology
KW - locoregional treatments
KW - hepatocellular carcinoma
UR - http://hdl.handle.net/10807/292318
U2 - 10.3390/cancers15153988
DO - 10.3390/cancers15153988
M3 - Article
SN - 2072-6694
VL - 15
SP - N/A-N/A
JO - Cancers
JF - Cancers
ER -